Bulky stage Ib and II squamous cell carcinoma of the uterine cervix treated by combined preoperative radiation therapy and surgery

被引:0
|
作者
Touboul, E [1 ]
Lefranc, JP [1 ]
Belkacemi, Y [1 ]
Rogel, A [1 ]
Deluen, F [1 ]
Blondon, J [1 ]
Housset, M [1 ]
机构
[1] Hop Tenon, Serv Oncol Radiotherapie, Ctr Tumeurs, F-75020 Paris, France
来源
CONTRACEPTION FERTILITE SEXUALITE | 1998年 / 26卷 / 09期
关键词
bulky squamous cell carcinoma of the uterine cervix; prognostic factors; combination therapy; radiation therapy; chemotherapy; surgery; para-aortic lymph; node control;
D O I
暂无
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Fifty-two women with stage Ib2 and II bulky squamous cell carcinoma of the uterine cervix (mean size : 5,65 +/- 0, 12 cm, range : 5-8 cm) were treated between July 1982 and December 1993. The median follow-up was 73 months. Their patient's age ranged from 25 to 77 years (median : 45 years). There were 18 stage Ib2, 8 stage IIa and 26 stage IIb operable patients. External radiotherapy was delivered using photons of 6 MV to 25 MV and a four-field <<box>> technique (upper limit situated between L4-L5). Mean total dose at mid-plane to the whole pelvis was 38.6 Gy (range : 37.4-40.6 Gy) in 18 fractions over 30 days. A boost dose of 20 Gy was given by intracavitary brachytherapy (utero-vaginal). After a mean rest of 48 days, total abdominal hysterectomy and bilateral salpingo-oophorectomy combined with bilateral pelvic lymphadenectomy was performed. Following surgery no remaining tumor on pathological examination of uterine cervix was observed in 39 cases (75 %) and positive external iliac nodes were found in 4 cases. Five- and 10-year specific survival rates were 80 % and 75 %, respectively. The 5-year local tumour recurrence and nodal recurrence rates were 18 % and 15 %, respectively There were 7 para-aortic nodal recurrences (3 were isolated para-aortic nodal relapses). There were five late severe complications necessiting surgical intervention. A combination of preoperative radiation therapy and concomitant chemotherapy and the extended dissection of common iliac and para-aortic lymph nodes or a post operative prophylactic extended field irradiation including para-aortic lymph nodes is now being attempted in order to improve the locoregional tumour and para-aortic lymph node control rates.
引用
收藏
页码:674 / 685
页数:12
相关论文
共 50 条
  • [21] Class II Radical Hysterectomy in Low-Risk IB Squamous Cell Carcinoma of Cervix A Safe and Effective Option
    Cai, Hong-Bing
    Chen, Hui-Zhen
    Zhou, Yun-Feng
    Lie, Dao-Mei
    Hou, Han-Yin
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2009, 19 (01) : 46 - 49
  • [22] Squamous cell carcinoma of the oropharynx - Surgery, radiation therapy, or both
    Parsons, JT
    Mendenhall, WM
    Stringer, SP
    Amdur, RJ
    Hinerman, RW
    Villaret, DB
    Moore-Higgs, GJ
    Greene, BD
    Speer, TW
    Cassisi, NJ
    Million, RR
    CANCER, 2002, 94 (11) : 2967 - 2980
  • [23] Primary surgery versus primary radiation therapy for FIGO stages I-II small cell carcinoma of the uterine cervix: A retrospective Taiwanese Gynecologic Oncology Group study
    Chen, Tze-Chien
    Huang, Huei-Jean
    Wang, Tao-Yeuan
    Yang, Lan-Yan
    Chen, Chi-Hau
    Cheng, Ya-Min
    Liou, Wen-Hsiung
    Hsu, Shih-Tien
    Wen, Kuo-Chang
    Ou, Yu-Che
    Hung, Yao-Ching
    Lai, Hung-Cheng
    Ho, Chih-Ming
    Chang, Ting-Chang
    GYNECOLOGIC ONCOLOGY, 2015, 137 (03) : 468 - 473
  • [24] Comparison of the Prognoses of FIGO Stage I to Stage II Adenosquamous Carcinoma and Adenocarcinoma of the Uterine Cervix Treated With Radical Hysterectomy
    Mabuchi, Seiji
    Okazawa, Mika
    Kinose, Yasuto
    Matsuo, Koji
    Fujiwara, Masateru
    Suzuki, Osamu
    Morii, Eiichi
    Kamiura, Shoji
    Ogawa, Kazuhiko
    Kimura, Tadashi
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2012, 22 (08) : 1389 - 1397
  • [25] A phase II study of concurrent chemo-radiotherapy with weekly nedaplatin in advanced squamous cell carcinoma of the uterine cervix
    Yuan, Guangwen
    Wu, Lingying
    Huang, Manni
    Li, Nan
    An, Jusheng
    RADIATION ONCOLOGY, 2014, 9
  • [26] Phase II study of irinotecan combined with mitomycin-C for advanced or recurrent squamous cell carcinoma of the uterine cervix: the JGOG study
    Umesaki, N
    Fujii, T
    Nishimura, R
    Tanaka, T
    Nishida, M
    Fushiki, H
    Takizawa, K
    Yamamoto, K
    Hasegawa, K
    Izumi, R
    GYNECOLOGIC ONCOLOGY, 2004, 95 (01) : 127 - 132
  • [27] Analysis of recurrence of squamous cell carcinoma of the uterine cervix after definitive radiation therapy alone: Patterns of recurrence, latent periods, and prognosis
    Sakurai, H
    Mitsuhashi, N
    Takahashi, M
    Akimoto, T
    Muramatsu, H
    Ishikawa, H
    Imai, R
    Yamakawa, M
    Hasegawa, M
    Niibe, H
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2001, 50 (05): : 1136 - 1144
  • [28] Docetaxel and carboplatin chemotherapy for treating patients with stage IVB or recurrent non-squamous cell carcinoma of the uterine cervix: a phase II study
    Shimada, Muneaki
    Sato, Shinya
    Shoji, Tadahiro
    Nagao, Shoji
    Tokunaga, Hideki
    Sueoka, Kotaro
    Takehara, Kazuhiro
    Nakamura, Keiichiro
    Yamaguchi, Satoshi
    Kigawa, Junzo
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2021, 26 (07) : 1314 - 1321
  • [29] Docetaxel and carboplatin chemotherapy for treating patients with stage IVB or recurrent non-squamous cell carcinoma of the uterine cervix: a phase II study
    Muneaki Shimada
    Shinya Sato
    Tadahiro Shoji
    Shoji Nagao
    Hideki Tokunaga
    Kotaro Sueoka
    Kazuhiro Takehara
    Keiichiro Nakamura
    Satoshi Yamaguchi
    Junzo Kigawa
    International Journal of Clinical Oncology, 2021, 26 : 1314 - 1321
  • [30] Combined modality therapy for patients with esophageal squamous cell carcinoma: Radiation dose and survival analyses
    Shueng, Pei-Wei
    Huang, Chun-Chieh
    Liu, Yu-Ming
    Wu, Yuan-Hong
    Huang, Pin-, I
    Yen, Sang-Hue
    Lin, Kuan-Heng
    Hsu, Chen-Xiong
    THORACIC CANCER, 2023, 14 (02) : 143 - 148